ABSTRACT
We evaluated the ocular symptomatology in 3 HLA-A29 positive patients with uveitis. In two patients we saw bilateral flecked fundus lesions known as birdshot retinochoroidopathy. One patient with an idiopathic vasculitis had no depigmented fundus flecks. The differences and similarities in these 3 patients are described.
Subject(s)
HLA-A Antigens/immunology , Uveitis, Posterior/immunology , Anti-Inflammatory Agents/therapeutic use , Chorioretinitis/diagnosis , Chorioretinitis/drug therapy , Chorioretinitis/immunology , Female , Fluorescein Angiography , Follow-Up Studies , Fundus Oculi , Humans , Male , Middle Aged , Prednisolone/therapeutic use , Uveitis, Posterior/diagnosis , Uveitis, Posterior/drug therapy , Vasculitis/diagnosis , Vasculitis/drug therapy , Vasculitis/immunology , Visual AcuityABSTRACT
In order to improve the determination of the causative agent in acute retinal necrosis syndrome, we evaluated the detection of intraocular antibody production to herpesviruses in 28 patients with this disease. Intraocular antibody production was determined by calculation of the Goldmann-Witmer coefficient whereby specific antibody titers in the inflamed eye and circulation are related to the total IgG content in ocular fluid and serum. Specific antibody titers to herpesviruses and Toxoplasma were determined by the indirect immunofluorescence technique. Thirty-five patients with ocular toxoplasmosis, cataract, or proliferative vitreoretinal disorders were tested as controls. By this technique, intraocular antibody production to varicella zoster virus or herpes simplex virus could be established in 16 (57%) of the patients with the typical clinical features of acute retinal necrosis, compared to none of the controls. Of the 33 affected eyes, 21 (64%) had a visual outcome of less than 20/200. We concluded that detection of intraocular antibody production to herpesviruses may be a useful diagnostic tool in establishing the causative agents in acute retinal necrosis.
Subject(s)
Antibodies, Viral/biosynthesis , Eye/immunology , Herpesviridae/immunology , Retinal Necrosis Syndrome, Acute/microbiology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prognosis , Retinal Necrosis Syndrome, Acute/physiopathologyABSTRACT
Group G streptococci can cause serious infections in patients with predisposing factors. Involvement of the eye has rarely been reported in patients without ocular history. Two cases of group G streptococcal endocarditis which presented with an endogenous endophthalmitis are reported. Topical and systemic antimicrobial therapy resulted in recovery, but visual outcome was poor.
Subject(s)
Endocarditis, Bacterial/complications , Endophthalmitis/etiology , Streptococcal Infections/complications , Aged , Aged, 80 and over , Endocarditis, Bacterial/drug therapy , Female , Humans , Streptococcal Infections/drug therapyABSTRACT
PURPOSE: To investigate whether the cytokine interleukin-8 (IL-8), a strong chemoattractant and activator for neutrophils, is responsible for neutrophil infiltration and degranulation in the eye in uveitis. METHODS: IL-8 and elastase were measured with specific enzyme-linked immunoassays in vitreous fluid samples obtained from 69 patients with various uveitis entities. Vitreous fluid of nonuveitis patients and eye bank eyes served as controls. The chemotactic activity of vitreous fluid was tested with the Boyden chamber technique. RESULTS: IL-8 was detected in 45% of the vitreous fluid samples from uveitis patients and in 26% of vitreous fluid samples from nonuveitis patients. Vitreous fluid samples with IL-8 levels exceeding 100 pg/ml were chemotactic for neutrophils. This chemotactic activity could be blocked by 41% to 79% with a monoclonal anti-IL-8 antibody. Elastase levels in vitreous fluid of uveitis patients with detectable IL-8 were significantly higher than those in vitreous fluid samples with no detectable IL-8. CONCLUSION: These results indicate that IL-8 participates in the inflammatory processes in the eye by attracting and degranulating neutrophils. It is suggested that these processes contribute to the pathogenesis of tissue destruction in uveitis.
Subject(s)
Cell Degranulation/immunology , Chemotaxis, Leukocyte/immunology , Interleukin-8/immunology , Retinal Diseases/immunology , Uveitis/immunology , Vitreous Body/immunology , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Eye Diseases/enzymology , Eye Diseases/immunology , Humans , Neutrophils/immunology , Pancreatic Elastase/metabolism , Retinal Diseases/enzymology , Uveitis/enzymology , Vitreous Body/enzymologyABSTRACT
In 19 patients who had retinal vein occlusion or retinal artery occlusion before the age of 50 years, the incidence of hyperhomocysteinemia, as observed in heterozygosity for homocystinuria, was studied by the performance of a standardized, oral methionine-loading test. In four of the 19 patients (21%), two with retinal artery occlusion and two with central retinal vein occlusion, the after-load peak levels of homocysteine exceeded the mean level, established in normal control subjects, by more than two standard deviations and were as well within the ranges established in obligate heterozygotes for homocystinuria. Because the frequency of heterozygosity for homocystinuria in the normal population is one in 70 (1.4%) at the most, we conclude that hyperhomocysteinemia predisposes to the development of premature retinal artery and retinal vein occlusion (P < .01; chi 2 test).
Subject(s)
Homocysteine/blood , Retinal Artery Occlusion/blood , Retinal Vein Occlusion/blood , Adult , Biomarkers/blood , Female , Humans , Male , Methionine , Pyridoxine/therapeutic use , Reference Values , Retinal Artery Occlusion/drug therapy , Retinal Artery Occlusion/physiopathology , Retinal Vein Occlusion/drug therapy , Retinal Vein Occlusion/physiopathology , Smoking , Visual AcuityABSTRACT
Several studies suggest a role for IL-6 in the pathogenesis of uveitis. Earlier we have shown that aqueous humour obtained from patients with uveitis contained raised levels of IL-6. In the study described here we investigated the IL-6 levels in vitreous fluid samples obtained from 75 uveitis patients with different uveitis entities. Vitreous samples from 14 patients with proliferative intraocular disorders (PID) and 29 eye bank eyes were used as controls. All the samples were tested in the IL-6 B9 bioassay as well as in a sensitive ELISA for IL-6. Raised IL-6 levels were detected in the vitreous fluid of uveitis patients as well as patients with PID, implicating IL-6 as a common inflammatory mediator. The highest mean level of IL-6 was found in the vitreous fluid of patients with acute retinal necrosis. The mean IL-6 levels measured by the ELISA were higher compared to the levels measured by the B9 bioassay. This may be caused by the presence of B9 bioassay inhibitory factors in the vitreous fluid of these patients.
Subject(s)
Eye Diseases/immunology , Interleukin-6/analysis , Uveitis/immunology , Vitreous Body/immunology , Biological Assay , Enzyme-Linked Immunosorbent Assay , Eye Banks , HumansABSTRACT
Proliferative vitreoretinopathy (PVR) was induced in rabbits by intravitreal injection of homologous fibroblasts. During the 8 weeks after injection the immune responsiveness to three purified retinal autoantigens was studied. From 2 weeks after injection, animals that developed serious forms of PVR exhibited definite mitotic responses of their lymphocytes to stimulation by the retinal antigens. These responses could consistently be demonstrated for S-antigen and interphotoreceptor retinoid-binding protein (IRBP) during the subsequent period of examination. Marked responses were also noted to opsin, however, their occurrence was more variable. In mild forms of PVR or in controls the responses were weak or absent. This showed that the elevated cellular reactivities were induced by the development of PVR and not by some other experimental factor. Humoral immune responses to the three antigens were absent (as assayed by ELISA). The control groups did not exhibit any elevated immune responsiveness. There appears to be accumulating evidence that inflammation may play a role in the development of PVR. The present results indicate that cellular autoimmune responses to photoreceptor antigens are a secondary phenomenon in PVR, nevertheless, they may be an important factor in the subsequent development of severe PVR. This autosensitization may consequently be taken into consideration in the treatment of complicated human PVR.